Tectonic Therapeutic | AVRO - Creditori Commerciali

Prezzo Delle Azioni
30.71
Cambio Giornaliero
-0.39 -1.24%
Mensile
-11.74%
Annuale
90.01%
Q2 Previsione
29.60




Creditori Commerciali Cambiamento Data
Akebia Therapeutics USD 21.18M 11.1M 2025-12
Alnylam Pharmaceuticals USD 115.72M 1.87M 2025-12
Celltrion KRW 104.19B 15.67B 2025-09
Cspc Pharmaceutical CNY 2.32B 236.83M 2025-12
Deva Holding AS TRY 809.81M 105.88M 2023-09
Dianthus Therapeutics USD 9.72M 3.02M 2025-12
Divis Laboratories Ltd INR 10.4B 1.3B 2025-09
Gilead Sciences USD 808M 226M 2025-09
Ionis Pharmaceuticals USD 14.33M 8.47M 2025-09
Kangmei Pharma CNY 2.61B 176.42M 2025-09
Karyopharm Therapeutics USD 4M 1.39M 2025-12
Knight Therapeutics CAD 125.76M 7.63M 2025-12
Laboratorios Farma EUR 107.59M 341K 2023-12
MacroGenics USD 4.79M 1.15M 2025-12
Malin Corporation EUR 700K 200K 2024-12
Medical Developments International AUD 4.31M 2.18M 2025-12
Neuren Pharmaceuticals AUD 2.4M 4.26M 2025-12
Organigram Holdings CAD 71.08M 18.17M 2025-12
Ovoca Bio EUR 186K 23K 2025-06
Pfizer USD 5.02B 142M 2025-09
Pharma Mar EUR 54.34M 10.54M 2025-12
Qiagen NV USD 72.66M 2.11M 2025-12
Roche Holding CHF 5.78B 1.27B 2025-12
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Sanofi EUR 22.93B 927M 2025-12
Sarepta Therapeutics USD 280.84M 186.83M 2025-12
Sartorius EUR 323.2M 61M 2025-09
Sino Biopharmaceutical CNY 2.82B 1.32B 2025-06
Takeda JPY 467.59B 28.61B 2025-12
Tilray USD 114.5M 3.69M 2025-09
Zealand Pharma A/S 346.6M 102.71M 2025-12
Zz Pientze Pharmaceu CNY 516.14M 31.53M 2025-09